Related references
Note: Only part of the references are listed.Benchmarking the Incidence and Mortality of Severe Sepsis in the United States
David F. Gaieski et al.
CRITICAL CARE MEDICINE (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Richard S. Hotchkiss et al.
LANCET INFECTIOUS DISEASES (2013)
SEPSIS: MULTIPLE ABNORMALITIES, HETEROGENEOUS RESPONSES, AND EVOLVING UNDERSTANDING
Kendra N. Iskander et al.
PHYSIOLOGICAL REVIEWS (2013)
Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction
Elizabeth E. Gardiner et al.
BLOOD REVIEWS (2012)
Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
Y. Levy et al.
CLINICAL INFECTIOUS DISEASES (2012)
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007
Tara Lagu et al.
CRITICAL CARE MEDICINE (2012)
Severe sepsis, coagulation, and fibrinolysis: Dead end or one way?
Francois Fourrier
CRITICAL CARE MEDICINE (2012)
Intensive versus conventional glucose control in critically ill patients: A meta-analysis of randomized controlled trials
Yan Ling et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
PAMPs and DAMPs: signal 0s that spur autophagy and immunity
Daolin Tang et al.
IMMUNOLOGICAL REVIEWS (2012)
Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign
Brian Casserly et al.
INTENSIVE CARE MEDICINE (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Protein C anticoagulant system-anti-inflammatory effects
Charles T. Esmon
SEMINARS IN IMMUNOPATHOLOGY (2012)
Crosstalk of the plasma contact system with bacteria
Katrin Faye Nickel et al.
THROMBOSIS RESEARCH (2012)
Neutrophil-derived IL-1β Is Sufficient for Abscess Formation in Immunity against Staphylococcus aureus in Mice
John S. Cho et al.
PLOS PATHOGENS (2012)
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
Jonathan S. Boomer et al.
CRITICAL CARE (2012)
Immunological hurdles of ageing: Indispensable research of the human model
Abbe N. Vallejo
AGEING RESEARCH REVIEWS (2011)
Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia A Randomized Trial
Richard G. Wunderink et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The Pathogenesis of Sepsis
Deborah J. Stearns-Kurosawa et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
A2B Adenosine Receptor Blockade Enhances Macrophage-Mediated Bacterial Phagocytosis and Improves Polymicrobial Sepsis Survival in Mice
Bryan G. Belikoff et al.
JOURNAL OF IMMUNOLOGY (2011)
From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism?
J. I. Borissoff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Point: Adherence to Early Goal-Directed Therapy Does It Really Matter? Yes. After a Decade, the Scientific Proof Speaks for Itself
Emanuel P. Rivers
CHEST (2010)
Hypoglycemia is associated with intensive care unit mortality
Jeroen Hermanides et al.
CRITICAL CARE MEDICINE (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
Mitchell M. Levy et al.
INTENSIVE CARE MEDICINE (2010)
Early Enhanced Local Neutrophil Recruitment in Peritonitis-Induced Sepsis Improves Bacterial Clearance and Survival
Florin L. Craciun et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
Jacqueline Unsinger et al.
JOURNAL OF IMMUNOLOGY (2010)
CLINICAL IMMUNOLOGY Culprits with evolutionary ties
Carolyn S. Calfee et al.
NATURE (2010)
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Qin Zhang et al.
NATURE (2010)
Sepsis biomarkers: a review
Charalampos Pierrakos et al.
CRITICAL CARE (2010)
Safety and Efficacy of Corticosteroids for the Treatment of Septic Shock: A Systematic Review and Meta-Analysis
Wendy I. Sligl et al.
CLINICAL INFECTIOUS DISEASES (2009)
A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis
Nathan I. Shapiro et al.
CRITICAL CARE MEDICINE (2009)
Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis
Marcin F. Osuchowski et al.
CRITICAL CARE MEDICINE (2009)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN DIABETES ASSOCIATION CONSENSUS STATEMENT ON INPATIENT GLYCEMIC CONTROL
Etie S. Moghissi et al.
ENDOCRINE PRACTICE (2009)
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
Jean-Charles Preiser et al.
INTENSIVE CARE MEDICINE (2009)
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults A Systematic Review
Djillali Annane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Intensive versus Conventional Glucose Control in Critically Ill Patients
S. Finfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MECHANISMS OF DISEASE Cell Death
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
Xin Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Use of procalcitonin to shorten antibiotic treatment duration in septic patients - A randomized trial
Vandack Nobre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Moving toward preventive therapy in acute lung injury
Naeem A. Ali
CRITICAL CARE MEDICINE (2008)
Steroid therapy of septic shock: The decision is in the eye of the beholder
R. Phillip Dellinger
CRITICAL CARE MEDICINE (2008)
Apoptosis in sepsis: Mechanisms, clinical impact and potential therapeutic targets
Alfred Ayala et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Hydrocortisone therapy for patients with septic shock
Charles L. Sprung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Early events in the recognition of danger signals after tissue injury
David J. Kaczorowski et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon
Tanya M. Binette et al.
BLOOD (2007)
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
Fernando A. Bozza et al.
CRITICAL CARE (2007)
Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis
Wendy A. Luce et al.
CRITICAL CARE (2007)
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial
H. Saito et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Diagnosis of adrenal insufficiency in severe sepsis and septic shock
Djillali Annane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Early goal-directed therapy in severe sepsis and septic shock revisited - Concepts, controversies, and contemporary findings
Ronny M. Otero et al.
CHEST (2006)
Apoptosis and caspases regulate death and inflammation in sepsis
Richard S. Hotchkiss et al.
NATURE REVIEWS IMMUNOLOGY (2006)
International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients
Claudia Voves et al.
BLOOD COAGULATION & FIBRINOLYSIS (2006)
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality
Marcin F. Osuchowski et al.
JOURNAL OF IMMUNOLOGY (2006)
Variability of blood glucose concentration and short-term mortality in ctitically ill patients
Moritoki Egi et al.
ANESTHESIOLOGY (2006)
Disseminated intravascular coagulation in sepsis
S Zeerleder et al.
CHEST (2005)
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
E Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects
M Turina et al.
CRITICAL CARE MEDICINE (2005)
Intracellular and surface distribution of monocyte tissue factor - Application to intersubject variability
EM Egorina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways
RS Hotchkiss et al.
JOURNAL OF IMMUNOLOGY (2005)
Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity
R Taneja et al.
CRITICAL CARE MEDICINE (2004)
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation
J Chou et al.
BLOOD (2004)
Immunomodulatory role of CXCR2 during experimental septic peritonitis
TL Ness et al.
JOURNAL OF IMMUNOLOGY (2003)
Sepsis and disseminated intravascular coagulation
M Levi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2003)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
E Abraham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
C-reactive protein levels correlate with mortality and organ failure in critically ill patients
SMA Lobo et al.
CHEST (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cytokine therapeutics for the treatment of sepsis: Why has nothing worked?
DG Remick
CURRENT PHARMACEUTICAL DESIGN (2003)
Six at six: Interleukin-6 measured 6 H after the initiation of sepsis predicts mortality over 3 days
DG Remick et al.
SHOCK (2002)
Endothelium: Interface between coagulation and inflammation
M Levi et al.
CRITICAL CARE MEDICINE (2002)
Endothelial cell apoptosis in sepsis
RS Hotchkiss et al.
CRITICAL CARE MEDICINE (2002)
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
E Rivers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure
JM Adams et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2001)
Usefulness of procalcitonin serum level for the diagnosis of bacteremia
S Liaudat et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans
RS Hotchkiss et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro
MJ Sylte et al.
INFECTION AND IMMUNITY (2001)
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
RS Hotchkiss et al.
NATURE IMMUNOLOGY (2000)